This opportunity is no longer accepting applications.
grant PAR-21-208

Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

The CEBRA grant from the National Institute on Drug Abuse supports innovative research in substance use disorders. It targets high-risk, high-impact studies not covered by current projects, with the potential to transform the field. Research should develop groundbreaking techniques or test new hypotheses with little prior data, aiming to revolutionize addiction research and treatment approache…

The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentia…

Funding Source

Agency: National Institutes of Health
Program: SBIR

Awards & funding

Award Ceiling: $150,000
Award Amount: $150,000

Dates

Open for Submission: March 26, 2021
Opportunity Released: March 26, 2021
Submission Deadline: August 14, 2024
Application Window Closes: August 14, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.